Retatrutide vs Semaglutide & Tirzepatide: Should YOU Actually Take It? copertina

Retatrutide vs Semaglutide & Tirzepatide: Should YOU Actually Take It?

Retatrutide vs Semaglutide & Tirzepatide: Should YOU Actually Take It?

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
Retatrutide is the most powerful weight loss peptide ever studied—a triple agonist hitting GLP-1, GIP, AND glucagon receptors, producing up to 28.7% body weight loss in Phase 3 data. But being the BEST at weight loss doesn't automatically make Retatrutide the best peptide for YOU. The answer depends on your starting weight, your metabolic health, your cardiovascular risk, and whether you're chasing fat loss or longevity. In this video, Dr. Quinn Stillson (MD + strength coach) breaks down the complete science behind Retatrutide and compares it head-to-head against Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)—separating what the data actually shows from what the peptide community assumes. We cover the structure, the triple-receptor mechanism, the real clinical data, the emerging side effect signals, and the longevity question most channels completely skip. By the end, you'll have a clear risk-benefit framework for deciding whether Retatrutide is right for your specific situation. In this video, you'll learn: What Retatrutide is and why the GIP backbone makes it structurally unique How biased agonism changes the GLP-1 potency story What GLP-1, GIP, and glucagon receptor activation each actually do The truth about the "increased energy expenditure" claim Real weight loss data vs Semaglutide and Tirzepatide The muscle/lean mass loss concern—and what the data shows Metabolic effects: liver fat, triglycerides, LDL, HDL, blood pressure, heart rate Why the level of evidence matters more than people think New side effects: dysesthesia, arrhythmias, discontinuation rates Should YOU take it if obese or diabetic? Should YOU take it if NOT obese or diabetic? Retatrutide and longevity: the GIP/Sirt1 and glucagon/AMPK paradoxes Best for: – Anyone considering Retatrutide for weight loss or body composition – People comparing GLP-1, dual, and triple agonists – Longevity-focused individuals weighing peptides for healthspan – Clinicians and biohackers wanting an evidence-based breakdown – Anyone tired of the hype who wants honest risk-benefit analysis Timestamps 00:00 Retatrutide = Best Peptide for Weight Loss, But Is It The Best Peptide For YOU? 01:15 Retatrutide Structure & How it Activates GLP-1, GIP, and Glucagon Receptors 05:31 GLP-1 Receptor Effects - Longevity, Weight, & Glycemic Control 08:12 GIP Receptor Effects - Metabolic Synergy & Questionable Longevity Effects 10:52 Glucagon Receptor Effects - Increased Energy Expenditure But Longevity Harm? 16:29 Retatrutide Weight Loss Effects (vs Semaglutide & Tirzepatide) 18:51 Muscle Loss Concern with Retatrutide (vs Semaglutide & Tirzepatide) 21:03 Retatrutide Metabolic Effects (Cholesterol, Liver Fat, Glycemic Control, Blood Pressure, HR) 25:30 Lower Level of Evidence for Retatrutide (vs Semaglutide & Tirzepatide) 28:17 Retatrutide Side Effects: Dysesthesia, Arrhythmias, More Severe GI Effects 30:05 Should YOU Take Retatrutide (If You’re Obese or Diabetic)? 33:20 Should YOU Take Retatrutide (If You’re NOT Obese or Diabetic)? 36:25 Retatrutide for Anti-Aging & Lifespan Extension (vs Semaglutide & Tirzepatide) 41:02 Is Retatrutide the Best GLP-1 for YOU & Free Peptide Guide Get the free peptide guide at my website: quinnstillsonmd.com Purchase the Hume Body Pod below (FSA/HSA eligible) — up to 50% off! Code: QUINN https://humehealth.com//discount/QUINN?redirect=/pages/hume-body-pod&utm_source=youtube&utm_medium=influencer&utm_campaign=QUINN Related Video Top 5 Peptides for Longevity → https://youtu.be/22mUkD8bNds Subscribe for weekly videos on peptides, longevity & performance Next: How to Use Retatrutide – The Complete Practical Guide Medical Disclaimer This video is for educational purposes only and does not constitute medical advice. Retatrutide is not FDA-approved and is currently available for research purposes only. Long-term safety and efficacy in humans have not been established. Always consult a qualified healthcare provider before starting any peptide or medical therapy. #Retatrutide #GLP1 #Peptides #WeightLoss #Tirzepatide #Semaglutide #Longevity
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione